$2
Pharmaceutical Litigation
Case results reflect publicly available information reported by the listed law firms. They are not results obtained by ThatCarHitMe.com. Every case is unique and must be evaluated on its own facts. Prior results do not guarantee a similar outcome. The results shown are not necessarily representative of all results obtained by these firms. No representation is made that the quality of legal services to be performed is greater than the quality of legal services performed by other lawyers.
Case Details
Johnson & Johnson fined for promoting the antipsychotic medication Risperdal for off-label use in treatment of nursing home residents with dementia, leading to civil and criminal penalties.
Additional Notes
The firm states they have represented many nursing home residents injured or deceased due to over-medication, implying this case highlights the type of issues they address. The promotion of this drug for non-approved use placed many elderly nursing home residents at risk for strokes and development of diabetes. Source: U.S. Department of Justice.
Represented By